Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. [electronic resource]
Producer: 20120926Description: 2129-41 p. digitalISSN:- 1178-2013
- Aluminum Compounds -- chemistry
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Antihypertensive Agents -- administration & dosage
- Cell Line
- Cell Survival -- drug effects
- Delayed-Action Preparations
- Drug Stability
- Hepatocytes -- drug effects
- Humans
- Intercalating Agents
- Metal Nanoparticles -- chemistry
- Microscopy, Electron, Scanning
- Models, Molecular
- Nanocomposites -- administration & dosage
- Nanomedicine
- Nitrates -- chemistry
- Perindopril -- administration & dosage
- Powder Diffraction
- Spectroscopy, Fourier Transform Infrared
- Surface Properties
- Zinc -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.